ETF及指数产品网格策略周报（2025/11/11）

Group 1 - The article discusses the potential investment opportunities in ETFs related to military, pharmaceutical, and new economy sectors, driven by China's strategic planning and budget allocations [3][4][10]. - The military sector ETF (512710.SH) is expected to benefit from China's defense budget increase to 1.81 trillion yuan in 2025, a 7.2% year-on-year growth, although still below the global average as a percentage of GDP [3][4]. - The pharmaceutical ETF (512010.SH) is positioned to capitalize on the unprecedented support for innovative drug development in China, with a significant increase in the number of drug pipelines and licensing agreements, reaching over 66 billion USD in total licensing amounts in the first half of 2025 [7][8]. Group 2 - The Hang Seng New Economy ETF (513320.SH) aims to leverage China's push for high-level technological self-reliance and the ongoing global economic easing, which creates a favorable environment for growth in sectors like internet, semiconductors, and renewable energy [10][11]. - The article highlights the strategic importance of the "14th Five-Year Plan" and the upcoming "15th Five-Year Plan" in shaping investment opportunities across these sectors, particularly in response to global geopolitical dynamics [3][10]. - The ETFs mentioned are expected to provide exposure to leading companies in their respective fields, benefiting from the anticipated improvements in industry fundamentals and government policies [4][7][10].